25th -
26th
February 2025
February 2025 | 
Dublin, Ireland

Ireland's Sole Biologics Manufacturing & Logistics Gathering

25th -
26th
February 2025 | 
Dublin, Ireland
📆 Add to Google Calendar
Presentation
0 +
Organizations
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

With USD 9.9 billion investment in new biopharmaceutical production facilities in Ireland over the previous ten years for new biotech manufacturing facilities, Ireland has recently become a place of choice for biopharmaceutical manufacturing. There are manufacturing facilities here for nine of the top ten pharmaceutical firms in the world, including Novartis, AbbVie, Janssen, Pfizer, Sanofi, GlaxoSmithKline, MSD, Bristol-Myers Squibb, and Takeda.

For instance, AstraZeneca invested USD 64 million on Irish manufacturing and R&D growth in June 2022; this will increase Alexion's capacity to produce drug substances in Ireland. The manufacturing facility for Johnson & Johnson in Ringaskiddy, Ireland finished a USD 354 million expansion, and now it has plans to increase the site's capacity even further. At its facility in Cork, Merck kGaA will invest more than USD 421 million in May 2022 to increase its production capabilities for membrane and filtering. Additionally, Takeda is establishing a single-use facility for the company's rare disease portfolio, MSD is building a facility to manufacture Keytruda, and BMS will manufacture its immuno-oncology drugs at a new USD 900 million plant in Dublin.

There are no indicators that investment in Ireland's biomanufacturing industry will decrease. The country's existing businesses are expanding their facilities, and new businesses are trying to establish themselves on the Emerald Isle. One such company is WuXi Biologics from China, which intends to construct the largest single-use manufacturing facility in the world in Dundalk, Ireland, as a new vaccine manufacturing facility.

Ireland’s strength in the bio manufacturing sector is down to a number of factors, and, whilst tax incentives are important, they are not the ultimate factor. The pharma industry is a prime example of what Moran refers to as the "knowledge-based sector," which was the focus of government expenditure and initiatives. Consider the Irish government's funding of the University College Dublin-based National Institute for Bioprocessing Research & Training (NIBRT). It is currently one of the top institutions in the world for training courses to support sophisticated biomanufacturing procedures.

IDA Ireland anticipates ongoing investment in 2021 despite the epidemic. The organization is starting a new "Strategy 2021-2024" with a focus on five pillars: growth, transformation, regions, sustainability, and impact. This strategy aims to attract 800 investments and create 50,000 new employment. The Irish government is devoted to keeping up its investments in research and education to make sure that Ireland continues to be a popular choice for new biotechnology manufacturing enterprises.

FEATURED CONTENT

Ebook Cover_IBS24_Bigpharma Manufacturing in Ireland
Leading Biopharma Manufacturing Companies in Ireland
ireland1
Ebook: Biomanufacturing in Ireland
IBS
Biomanufacturing Landscape in Ireland
Biomanufacturing Ireland 2025

Industry 4.0 and Smart Manufacturing

Cell Line Development & Engineering and Cell Culture

Innovation in Product Purification & Concentration

.
.
.

Bioprocessing Excellence & Best Practices

.

THANK YOU TO OUR SUPPORTING PARTNERS









Biomanufacturing Ireland 2025

Past Speakers

Abina

Abina Crean

Professor of Pharmaceutics

University College Cork
Ireland
Alexander Russel

Alexander Russell

Associate Director - Technical Operations

Abbvie
Ireland
Andrew Kelly

Andrew Kelly

Director, Manufacturing Technology

Bristol Myers Squibb
Ireland
Anthony-Newcombe_photo_profile-3

Anthony Newcombe

Managing Director Operations

Applied Biopharm
Ireland
Colin Clarke

Colin Clarke

Principal Investigator - Systems Biology & Data Analytics Group

NIBRT
Ireland
Dan-Bach-Kristensen_photo_profile-3

Dan Bach Kristensen

Principal Scientist

Symphogen
Denmark
Eimear O’Leary

Eimear O’Leary

Director of Communications and Advocacy

IPHA
Ireland
Filipa

Filipa Almeida

Upstream Lead - MSAT

Barinthus Biotherapeutics
United Kingdom
Guglielmo Lozzia

Guglielmo Lozzia

Associate Director - ML/A

MSD
Ireland
Heidi-Zhang_photo_profile-3

Heidi Zhang

EVP, Head of TechOps

Tune Therapeutics,
USA
Jamie Guidera

Jamie Guidera

Commercialisation Manager

SSPC Research Centre
Ireland
Keelan Moran

Keelan Moran

Operations Specialist

MSD
Ireland
Matt-Moran_photo_profile-3

Matt Moran

Life Sciences and Biopharma Manufacturing Expert

BioPharmaChem
Ireland
Nan Zhang

Nan Zhang

Associate Professor - Manufacturing & Design, School of Mechanical and Materials Engineering

University College Dublin
Ireland
ruioliveira_0

Rui Oliveira

Associate Professor

NOVA School of Science & Technology
Ireland
Ryan Griffin

Ryan Griffin

Director of Site Quality

Abbvie
Ireland
MicrosoftTeams-image (21)

Sakis Mantalaris

Principal Investigator - Bioprocess Systems Engineering Group

NIBRT
Ireland
Siobhan Dean

Siobhan Dean

Senior Executive

BioPharmaChem
Ireland

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

Local Biopharmas, Academics & Research Institutes
From ÂŁ 1050

Early Bird (valid until 15 November 2024)  
ÂŁ1050.00 ex VAT 

Standard (valid from 16 November - 14 February 2025) 
ÂŁ1250.00 ex VAT 

Final Call (valid from 15 February 2025 - 25 February 2025) 
ÂŁ1450.00 ex VAT 

*Local Biopharma & Academia pricing is not available for service and solution providers or representatives of Big Pharma  
**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
International Biopharmas & Big Pharmas
From ÂŁ1350

Early Bird (valid until 15 November 2024)  
ÂŁ1350.00 ex VAT 

Standard (valid from 16 November - 14 February 2025) 
ÂŁ1550.00 ex VAT 

Final Call (valid from 15 February 2025 - 25 February 2025) 
ÂŁ1750.00 ex VAT 

*Local Biopharma & Academia pricing is not available for service and solution providers or representatives of Big Pharma  
**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

Local Biopharmas, Academics & Research Institutes
From ÂŁ 1050

Early Bird (valid until 15 November 2024)  
ÂŁ1050.00 ex VAT 

Standard (valid from 16 November - 14 February 2025) 
ÂŁ1250.00 ex VAT 

Final Call (valid from 15 February 2025 - 25 February 2025) 
ÂŁ1450.00 ex VAT 

*Local Biopharma & Academia pricing is not available for service and solution providers or representatives of Big Pharma  
**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
International Biopharmas & Big Pharmas
From ÂŁ1350

Early Bird (valid until 15 November 2024)  
ÂŁ1350.00 ex VAT 

Standard (valid from 16 November - 14 February 2025) 
ÂŁ1550.00 ex VAT 

Final Call (valid from 15 February 2025 - 25 February 2025) 
ÂŁ1750.00 ex VAT 

*Local Biopharma & Academia pricing is not available for service and solution providers or representatives of Big Pharma  
**Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations

FEATURED CONTENT

Ebook Cover_IBS24_Bigpharma Manufacturing in Ireland
Leading Biopharma Manufacturing Companies in Ireland
ireland1
Ebook: Biomanufacturing in Ireland
IBS
Biomanufacturing Landscape in Ireland

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.

CCO,  
Regional Commercial Director  

Cold Chain Technologies

BMA was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.

Ciaran O'Keeffe,  
Director Business Development & Channel Sales  

MasterControl

With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!

Senior,  
Technical Account Specialist  

West Pharmaceutical Services

Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.

Nick Kotlarski,  
President, VP of BioManufacturing  

Bioworkshops Limited

The conference was a great success and fruitful.

Cai Bao,  
VP of BioManufacturing  

Biocon

Fantastic conference with professional team.

Julio Lin,  
VP  

Blue Blood Biotech

Informative session. Exhibition was well targeted and diverse. Presenters shared latest development

Sankar Dharmaraj,  
Head, GMP Operations  

Hilman Laboratories

It was an awesome experience to interact with so many energetic young professionals around the globe and share technical information. I want to express my heartfelt gratitude to the organizer for such a great event!

MD Atiqur Rahman,  
Senior Executive Officer, Professional (Sterile)  

Incepta

It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!

Koh Wei Jet,  
Sanofi  

EVF Project Process Manufacturing Leader

Great forum for face to face interactions and for exchange of ideas and information.

Chris Lee,  
Site head, Singapore Development and Manufacturing  

WuXi Biologics

The entire event was managed flawlessly by the Organizers. I personally did not face any technical glitches despite this even was organized in a hybrid manner. Almost every speaker gave a high quality presentation which was very insightful.

Chandrakant Kathote,  
Site Head & Vice President  

Lupin Ltd

It was really great experience for me to be associated with IMAPAC which organizes high standard conference. Speakers from various domains/fields are thoughtfully chosen & they have delivered the relevant fields of present post-covid pandemic biologics scenario.

Dr. Swapan Kumar Jana,  
Director R&D and Manufacturing  

Serum Institute Of India Pvt. Limited

A well organized ambitious meeting. I hope it will continue to develop in the future.

Jean Francois Dierick,  
Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development  

GSK Vaccines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Featured Content Form

Download List of Biopharma Companies in Asia Brochure

Download Ebook

Download Ebook

VWSEA2024 Brochure

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study

Download Ebook

Download Ebook

Download Events Calendar